Bharati R Dhruva

Array ( [id] => 5888642 [patent_doc_number] => 20020012995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Negative-sense RNA virus vector for nerve cell' [patent_app_type] => new [patent_app_number] => 09/843922 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11826 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20020012995.pdf [firstpage_image] =>[orig_patent_app_number] => 09843922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616253 [patent_doc_number] => 20020064802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Methods for binding an exogenous molecule to cellular chromatin' [patent_app_type] => new [patent_app_number] => 09/844662 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15167 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20020064802.pdf [firstpage_image] =>[orig_patent_app_number] => 09844662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356637 [patent_doc_number] => 20020058025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Stromal cell use' [patent_app_type] => new [patent_app_number] => 09/839711 [patent_app_country] => US [patent_app_date] => 2001-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8058 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058025.pdf [firstpage_image] =>[orig_patent_app_number] => 09839711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 518733 [patent_doc_number] => 07189705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers' [patent_app_type] => utility [patent_app_number] => 09/839707 [patent_app_country] => US [patent_app_date] => 2001-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 31760 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189705.pdf [firstpage_image] =>[orig_patent_app_number] => 09839707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 531670 [patent_doc_number] => 07179795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => 'Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor' [patent_app_type] => utility [patent_app_number] => 10/257384 [patent_app_country] => US [patent_app_date] => 2001-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 2941 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179795.pdf [firstpage_image] =>[orig_patent_app_number] => 10257384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 779279 [patent_doc_number] => 06995147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-07 [patent_title] => 'Method of delaying the onset of diabetes' [patent_app_type] => utility [patent_app_number] => 10/257221 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2965 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/995/06995147.pdf [firstpage_image] =>[orig_patent_app_number] => 10257221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7399639 [patent_doc_number] => 20040023332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Genes of il-12p40 subunit mutated for improving the activity of il-12 and thereof for dna vaccine adjuvant' [patent_app_type] => new [patent_app_number] => 10/221975 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15456 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023332.pdf [firstpage_image] =>[orig_patent_app_number] => 10221975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 903329 [patent_doc_number] => 07335646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Compositions and methods for regulated protein expression in gut' [patent_app_type] => utility [patent_app_number] => 09/804409 [patent_app_country] => US [patent_app_date] => 2001-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 18682 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335646.pdf [firstpage_image] =>[orig_patent_app_number] => 09804409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6881052 [patent_doc_number] => 20010032340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Controlling offspring\'s sex ratio by targeting transgenes onto the sex chromosomes' [patent_app_type] => new [patent_app_number] => 09/749709 [patent_app_country] => US [patent_app_date] => 2000-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3732 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20010032340.pdf [firstpage_image] =>[orig_patent_app_number] => 09749709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 425016 [patent_doc_number] => 07270998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Method of concentrating and separating dopaminergic neurons' [patent_app_type] => utility [patent_app_number] => 10/048536 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2803 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/270/07270998.pdf [firstpage_image] =>[orig_patent_app_number] => 10048536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7622205 [patent_doc_number] => 06977296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-20 [patent_title] => 'HUMAN CERVICAL CANCER SUPPRESSOR PROTEIN, POLYNUCLEOTIDE ENCODING THE PROTEIN, CELL TRANSFORMED WITH THE POLYNUCLEOTIDE AND METHOD FOR SUPPRESSING PROLIFERATION OF CANCER CELL USING THE EXPRESSION VECTOR' [patent_app_type] => utility [patent_app_number] => 10/257819 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 5335 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977296.pdf [firstpage_image] =>[orig_patent_app_number] => 10257819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33155 [patent_doc_number] => 07790870 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-09-07 [patent_title] => 'Membrane-anchored GP41 peptides that inhibit subsequent HIV viral entry' [patent_app_type] => utility [patent_app_number] => 10/148064 [patent_app_country] => US [patent_app_date] => 2000-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3606 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790870.pdf [firstpage_image] =>[orig_patent_app_number] => 10148064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 928306 [patent_doc_number] => 07314614 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-01-01 [patent_title] => 'Recombinant sendai virus vector for introducing exogenous genes to airway epithelia' [patent_app_type] => utility [patent_app_number] => 10/111356 [patent_app_country] => US [patent_app_date] => 2000-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6900 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314614.pdf [firstpage_image] =>[orig_patent_app_number] => 10111356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432322 [patent_doc_number] => 07265095 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-09-04 [patent_title] => 'Monoclonal antibody 3F1H10 neutralising VHSV (viral haemorrhagic septicaemia virus)' [patent_app_type] => utility [patent_app_number] => 10/088780 [patent_app_country] => US [patent_app_date] => 2000-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4448 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265095.pdf [firstpage_image] =>[orig_patent_app_number] => 10088780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 675930 [patent_doc_number] => 07087582 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-08 [patent_title] => 'Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21' [patent_app_type] => utility [patent_app_number] => 09/663889 [patent_app_country] => US [patent_app_date] => 2000-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6095 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087582.pdf [firstpage_image] =>[orig_patent_app_number] => 09663889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741481 [patent_doc_number] => 07030097 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-18 [patent_title] => 'Controlled nucleic acid delivery systems' [patent_app_type] => utility [patent_app_number] => 09/616711 [patent_app_country] => US [patent_app_date] => 2000-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 11736 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030097.pdf [firstpage_image] =>[orig_patent_app_number] => 09616711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741477 [patent_doc_number] => 07030096 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-18 [patent_title] => 'Method of enhancing relaxation of penile smooth muscle by introduction of DNA encoding maxi-K potassium channel protein' [patent_app_type] => utility [patent_app_number] => 09/531969 [patent_app_country] => US [patent_app_date] => 2000-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 33 [patent_no_of_words] => 23137 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030096.pdf [firstpage_image] =>[orig_patent_app_number] => 09531969 [rel_patent_id] =>[rel_patent_doc_number] =>)